Duration of evidence-based medical therapy and the hazard for atherothrombotic events following percutaneous coronary intervention

International Journal of Cardiology

Volumn 153, Issue 3, 2011, Pages 262-266

  Aronow, Herbert D ^a,b   Strawderman, Robert L ^c   Moscucci, Mauro ^d   Cowen, Mark E ^a  

^a ST JOSEPH MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Program on Infrastructure Policy   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin receptor blocerk; Beta blocker; Clopidogrel; Coronary artery disease; Statin; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FLUINDOSTATIN; FOSINOPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; MEVINOLIN; NADOLOL; PRAVASTATIN; PROPRANOLOL; QUINAPRIL; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; UNINDEXED DRUG; VALSARTAN;

ADULT; ARTICLE; ATHEROTHROMBOSIS; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; EVIDENCE BASED MEDICINE; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STENT THROMBOSIS; STROKE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY THROMBOSIS; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 81855199730     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.017     Document Type: Article

References (30)

1. P.B. Berger Optimal duration of clopidogrel use after implantation of drug-eluting stents-still in doubt N Engl J Med 362 2010 1441 1443
2. M.E. Bertrand, H.J. Rupprecht, P. Urban, A.H. Gershlick Investigators FT Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 102 2000 624 629 (Pubitemid 30640661)
3. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
4. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
5. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, and L. Wallentin Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019 (Pubitemid 46376801)
6. A.J. Nordmann, M. Briel, and H.C. Bucher Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Eur Heart J 27 2006 2784 2814 (Pubitemid 44871464)
7. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008 (Pubitemid 46376800)
8. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
9. A. Jeremias, B. Sylvia, and J. Bridges Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 2004 1930 1932 (Pubitemid 38544480)
10. D.W. Park, S.W. Park, and K.H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
11. S. Banerjee, C. Varghese, and J. Samuel Comparison of the impact of short (< 1 year) and long-term (> or = 1 year) clopidogrel use following percutaneous coronary intervention on mortality Am J Cardiol 102 2008 1159 1162
12. S.S. Brar, J. Kim, and S.K. Brar Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions J Am Coll Cardiol 51 2008 2220 2227 (Pubitemid 351754993)
13. A.W. Messerli, H.D. Aronow, and D.L. Sprecher The Lescol Intervention Prevention Study (LIPS): start all patients on statins early after PCI Cleve Clin J Med 70 2003 561 566
14. K. Ellis, J.E. Tcheng, S. Sapp, E.J. Topol, and A.M. Lincoff Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials J Interv Cardiol 16 2003 299 305 (Pubitemid 37047125)
15. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
16. (HCUP) HCaUP HCUP Clinical Classifications Software (CCS) for ICD-9-CM 6 ed. 2000-2003 Agency for Healthcare Research and Quality Rockville, MD
17. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model 2000 Springer-Verlag New York
18. H. Ishwaran, U.B. Kogalur, E.H. Blackstone, and M.S. Lauer Random survival forests Ann Appl Stat 2 2008 841 860
19. R Development Core Team R: A language and environment for statistical computing 2007 R Foundation for Statistical Computing Vienna, Austria
20. A.T. Ong, E.P. McFadden, E. Regar, P.P. de Jaegere, R.T. van Domburg, and P.W. Serruys Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2005 2088 2092 (Pubitemid 40814135)
21. D.F. Blackburn, R.T. Dobson, J.L. Blackburn, T.W. Wilson, M.R. Stang, and W.M. Semchuk Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study Can J Cardiol 21 2005 485 488 (Pubitemid 40823600)
22. M.J. Lenzen, E. Boersma, and M.E. Bertrand Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization Eur Heart J 26 2005 1169 1179 (Pubitemid 40863123)
23. B.A. Steinberg, P.G. Steg, D.L. Bhatt, G.C. Fonarow, U. Zeymer, and C.P. Cannon Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) Am J Cardiol 99 2007 1212 1215 (Pubitemid 46659862)
24. D.F. Blackburn, R.T. Dobson, J.L. Blackburn, and T.W. Wilson Cardiovascular morbidity associated with nonadherence to statin therapy Pharmacotherapy 25 2005 1035 1043 (Pubitemid 41099437)
25. G.C. Fonarow, A. Gawlinski, S. Moughrabi, and J.H. Tillisch Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822 (Pubitemid 32244197)
26. W.A. Jaber, R.J. Lennon, V. Mathew, D.R. Holmes Jr., A. Lerman, and C.S. Rihal Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator J Am Coll Cardiol 46 2005 1473 1478 (Pubitemid 41446181)
27. H.D. Aronow, G.M. Novaro, and M.S. Lauer In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis Arch Intern Med 163 2003 2576 2582 (Pubitemid 37464415)
28. A.M. Fendrick, and M.E. Chernew Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans J Gen Intern Med 22 2007 890 891 (Pubitemid 46763983)
29. M.A. Hernan, B. Brumback, and J.M. Robins Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 11 2000 561 570 (Pubitemid 30660035)
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150